Galmed To Design Phase III NASH Trial With FDA After Strong Aramchol Data

 
• By Sten Stovall
  
Obese
Talks To Follow 'Positive Top-Line Data' From Phase IIb ARREST study • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D